Evolus: Q1 Earnings Insights

Evolus (NASDAQ:EOLS) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM. Here’s what investors…

Evolus (NASDAQ:EOLS) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Evolus missed estimated earnings by 73.33%, reporting an EPS of $-0.26 versus an estimate of $-0.15.

Revenue was up $7.81 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08 which was followed by a 3.16% drop in the share price the next day.

Here’s a look at Evolus’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.15 -0.28 -0.24 -0.33
EPS Actual -0.23 -0.36 -0.42 -0.31
Revenue Estimate 43.79M 36.10M 36.63M 30.57M
Revenue Actual 43.65M 33.90M 37.16M 33.91M

To track all earnings releases for Evolus visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Cannabis MSO iAnthus Trims Net Loss In Q1, Reports YoY Increase In Revenue, Gross Profit

iAnthus Capital Holdings reported on Tuesday its financial results for the first quarter ended March 31, 2024.Revenue totaled $41.6 million, representing a sequential increase of 1.7% from the prior period and an increase of 13.1% year-over-year.Net loss totaled $14 million, or a net loss of less than $0.01 per share, compared to a net loss of $18.7 million, or a net loss of less than $0.01 per share in the prior quarter, and compared to a net loss of $18.6 million, or a net loss of $0.01 per share, in the prior year's period.

CSE:IAN